{
  "catalogId": "b5e358eb-41a3-489a-a9fc-59a2ef24656f",
  "name": "PIQRAY 150 MG",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "166 18 36148 00",
  "treatmentDescriptions": "PIQRAY is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ALPELISIB",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XX65",
      "name": "ALPELISIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "PIQRAY 50 MG 28 TAB",
      "manufacturer": {
        "name": "נוברטיס פארמה",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 28.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PCTFE",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8527",
        "yarpa": "28444",
        "pharmasoft": "10906",
        "barcode": "7290018375136"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": NaN,
        "retailMargin": NaN,
        "maxRetailPrice": NaN,
        "maxPriceWithVAT": NaN
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T06:44:50.254979"
  }
}